A Phase 3 interventional study of Cetylpyridinium Chloride, Zinc Lactate and Hyaluronic Acid Mouthwash and PhosFlur Mouthwash in Gingivitis, sponsored by Colgate Palmolive. Completed at 1 site in Italy. Open to participants aged 18 Years to 70 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2025-12-01.
Sponsored by Colgate Palmolive · Phase 3, Interventional, and Prevention
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 44 studies in Gingivitis by Colgate Palmolive — 8 open to participants now, 9 under way, 5 of them phase 3. Gingivitis · Colgate Palmolive.
Among the 44 studies in Gingivitis by Colgate Palmolive, this one is the 34th largest by enrollment, is the only one that started in 2021, is one of 25 in phase 3, and was the 27th registered.
631 studies on the registry are indexed under Gingivitis; 107 are open to participants now.
Browse Gingivitis studies →8 of the 44 studies in Gingivitis by Colgate Palmolive are open now, in 5 countries. Recruiting first, the newest first:
Colgate Palmolive · Sites in Italy
Ages 18–70 · Healthy volunteers
Colgate Palmolive · Sites in United States
Ages 18+
Colgate Palmolive · Sites in Germany
Ages 18–70 · Healthy volunteers
Colgate Palmolive · Sites in China
Ages 18–70 · Healthy volunteers
Colgate Palmolive
Ages 60+ · Healthy volunteers
By country, each count listing its studies:
Of the 53 Gingivitis studies recruiting now, 15 (28%) set no upper age limit and 36 (68%) stop at 75 or younger; 11 take children under 18; 35 take healthy volunteers.
This study: 18 Years to 70 Years · all sexes · healthy volunteers too.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
44 studies; the count open now beside each. This study's row is marked.
First in 2007; this study’s year is marked. 1 started in 2021.
By drug class, each counting the studies that test any of its medicines:
This study's enrollment of 80 is above the median of 66 across 507 interventional studies indexed under Gingivitis.
Median enrollment 94 across the 44 interventional studies. Of the 35 that completed or were terminated, 8 (23%) have results posted.
This tab as a report to print or save as PDF → With an account.
Colgate Palmolive is the lead sponsor of 120 studies on the registry; 14 are open to participants now.
Of its 36 completed or terminated interventional studies of FDA-regulated products, 2 (6%) have results posted.
5 of the studies in Gingivitis by Colgate Palmolive that are under way reach primary completion within a year, 3 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07605338Phase 3Colgate PalmoliveTo Assess the Efficacy of Two Brushing Regimens: in the Reduction of Established Dental Plaque and Gingivitis. | 2026-11 |
| NCT07842991Phase 3Colgate PalmoliveClinical Evaluation of a Toothpaste for Dental Plaque Reduction and Prevention of Gum Problems | 2027-01 |
| NCT07842978Phase 3Colgate PalmoliveClinical Study Examining the Control of Plaque and Gingivitis | 2027-04 |
| NCT06966492Colgate PalmoliveInvestigation of the Interplay Between Local Oral Inflammation, Microbiota and Systemic Immune Responses. | 2027-06 |
| NCT07807397Colgate PalmoliveOral Hygiene Assistance Training Program | 2027-09 |
Add all 5 to your calendar (.ics) → With an account.
Among the 44 studies in Gingivitis by Colgate Palmolive, from their registry updates:
This tab as a report to print or save as PDF → With an account.
The objective of this six-month clinical research study is to evaluate the clinical efficacy of a new mouthwash on helping prevent gum problems (gingival index scores ) in adults as compared to a control mouthwash.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
After brushing in the morning and in the evening, 20 ml of mouthwash shall be used for each rinsing, 2 times daily (morning and evening ) for 30 seconds each time. No further rinsing with water shall be occurred after spilt out and after each mouthwash rising. Each qualified subject will follow this specific application for 6 months
Drug: Cetylpyridinium Chloride, Zinc Lactate and Hyaluronic Acid Mouthwash
After brushing in the morning, 10 ml of mouthwash shall be used for each rinsing, 1 time daily (morning ) for 60 seconds each time. No further rinsing with water shall be occurred after spilt out and after each mouthwash rising. Each qualified subject will follow this specific application for 6 months.
Drug: PhosFlur Mouthwash
Drug pages: Cetylpyridinium · Zinc lactate · Hyaluronic Acid
0 .075 % cetylpyridinium chloride and 0 .28 % zinc lactate
0 .044 % sodium fluoride
Mombelli Modified Gingival Index
Initial mucositis index of at least 1.0 as determined by the use of the Mombelli Modified Gingival
Time frame: baseline
Mombelli Modified Gingival Index
Initial mucositis index of at least 1.0 as determined by the use of the Mombelli Modified Gingival
Time frame: three month
Mombelli Modified Gingival Index
Initial mucositis index of at least 1.0 as determined by the use of the Mombelli Modified Gingival
Time frame: six month
Mombelli Modified Plaque Index
Initial plaque index of at least 1 .5 as determined by the use of the Mombelli Modified Plaque
Time frame: baseline
Mombelli Modified Plaque Index
Initial plaque index of at least 1 .5 as determined by the use of the Mombelli Modified Plaque
Time frame: three month
Mombelli Modified Plaque Index
Initial plaque index of at least 1 .5 as determined by the use of the Mombelli Modified Plaque
Time frame: six month
Ran from Oct 2021 to primary completion in May 2022, 6 months.
Of 23 industry-sponsored phase 3 interventional studies under Gingivitis, half reached primary completion within 3 months of starting (the median), counting those still running; a quarter within 2 and three quarters within 6. This study's 6 months is above that.
Counting every sponsor, half of 35 studies reached it within 3 months; a quarter within 2 and three quarters within 6.
How these figures are worked out, and which studies are left out of them.
This study is completed, as verified in Jan 2025. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Studies of the drugs tested here: Cetylpyridinium · Zinc lactate · Hyaluronic Acid